SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095432
Filing Date
2024-08-12
Accepted
2024-08-12 16:11:13
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pali-20240630.htm   iXBRL 10-Q 1891363
2 EX-10.48 pali-ex10_48.htm EX-10.48 106558
3 EX-31.1 pali-ex31_1.htm EX-31.1 15927
4 EX-31.2 pali-ex31_2.htm EX-31.2 16158
5 EX-32.1 pali-ex32_1.htm EX-32.1 11173
  Complete submission text file 0000950170-24-095432.txt   7111964

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pali-20240630.xsd EX-101.SCH 1027785
56 EXTRACTED XBRL INSTANCE DOCUMENT pali-20240630_htm.xml XML 1076766
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 241196875
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)